Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-21

FDA Approved: TESTOSTERONE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TESTOSTERONE from Actavis Pharma, Inc. under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

SUPPL AP for TESTOSTERONE (TESTOSTERONE)